Medication info
Dirotan Plus Tablet 160/12.5 mg (Valsartan, Hydrochlorothiazide)

Dirotan Plus Tablet 160/12.5 mg (Valsartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
IYON Pharm. Co., Ltd.
Appearance
Dark red oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200808247 · Notified 2008.07.30 · Insurance code 658602050

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is necessary for patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or more). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
IYON Pharm. Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is necessary for patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or more). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any of the ingredients in this medication or have specific liver or kidney diseases should not take it. Caution is required if there are potassium levels and electrolyte imbalances, as blood pressure may suddenly drop too low. If symptoms of dizziness or fainting occur, consult a physician immediately. This medication may cause the skin to become sensitive to sunlight; therefore, sun exposure should be limited, and any skin reactions should be reported to a healthcare professional quickly. Use caution while driving or operating machinery, as dizziness or drowsiness may occur, and do not use potassium supplements or potassium-containing medications without consulting a doctor. Patients with poor kidney or liver function should regularly check their condition through blood tests while taking this medication. When taking this medication in combination with other drugs, it is essential to inform a doctor or pharmacist of the potential for interactions, especially with lithium, non-steroidal anti-inflammatory drugs, and other antihypertensives. Elderly patients, diabetic patients, and those with heart disease should take this medication more cautiously and consult a healthcare professional immediately if abnormal symptoms occur. In cases of overdose, hypotension and tachycardia may occur, and it is crucial to visit a hospital immediately for appropriate treatment. This medication should be kept out of the reach of children, protected from moisture, and stored in its original container.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, enteritis, hyperhidrosis, sensory impairment, insomnia, hypokalemia, hypotension, influenza, muscle cramps, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, abnormal sensations, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament strain, fainting, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, elevated serum potassium, dizziness, vasculitis, elevated liver function tests, vesicular dermatitis, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, intestinal vascular edema, hypokalemia, elevated blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, urticaria, skin rash, photosensitivity, necrotizing vasculitis, skin lupus erythematosus, decreased appetite, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorders, depression, abnormal sensations, visual impairment, leukopenia, bone marrow dysfunction, acute respiratory distress syndrome, pneumonia, pulmonary edema, acute kidney failure, kidney dysfunction, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, choroidal exudate, drowsiness, hypovolemia, arrhythmia, muscle stiffness, hypotension, tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is also advisable to keep it in a cool place, below 30 degrees Celsius, to maintain its efficacy over time.

Appearance and packaging

Appearance

Dark red oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.